3.667, 95% confidence interval: 1.07-12.54, p = 0.034). Conclusion: This study showed that there was a significantly increased trend in the incidence of candidemia with high mortality during the study period.
Candida species are the fourth most commonly isolated pathogens in patients with nosocomial bloodstream infections in the USA with similar trends reported worldwide, accounting for 8-10% of all bloodstream infections [1, 2] . The incidence of nosocomial candidemia is increasing in many hospitals [1, 3] . Candidemia is associated with prolonged hospital stay and high rates of morbidity and mortality. Critically ill patients are at particular risk for candidemia. According to the surveillance study reports, 25-50% of these infections occur among patients in intensive care units [4] . Intravascular catheters, broad-spectrum antibiotic therapy, previous surgical procedures, total parenteral nutrition, mucosal colonization, neutropenia and concomitant bacteremia are well-known possible risk factors for invasive Candida infections [5] [6] [7] . In this study, the incidence, etiology and risk factors associated with mortality for nosocomial candidemia were evaluated during a 4-year period in a teaching hospital. . An infection control nurse and an infectious disease specialist evaluated the patients by active surveillance methods. All demographic, microbiological and clinical data of the patients with nosocomial candidemia were obtained from medical records and were entered into standard data collection forms. Two cases with polymicrobial candidemia were excluded. Death was considered to be attibutable to candidemia if there was no other suspected cause for death. Blood culture was performed by automated blood culture system (Bactec 9240). Blood cultures that were positive for yeasts were subcultured on Sabouraud dextrose agar (Oxoid). The identification of Candida species was done by germ tube and biochemical testing using the ID 32C system (bioMérieux, France).
Subjects and Methods

Study Design
Definition
Nosocomial candidemia was defined as the presence of positive blood culture for Candida species in at least 1 blood culture sample using traditional microbiological procedures if they occurred 6 48 h after hospital admission with concomitant signs and symptoms of infection according to the criteria of the Centers for Disease Control and Prevention [8] . Incidence density was defined as the number of nosocomial candidemia per 10,000 patient-days.
Statistical Analysis
Statistical analysis of data was performed using the NCSS 2007 and PASS 2008 Statistical Software (Utah, USA) programs. The 2 test and Fisher's exact test were used to evaluate the association between categorical quantitative variables. The changes in the incidence rates and distribution of the nosocomial candidemia were analyzed by the 2 test for trend. Univariate analyses were performed to identify risk factors associated with mortality. The odds ratio with 95% confidence interval was calculated. A p value of less than 0.05 was considered to be statistically significant. A p value of less than 0.001 was considered to be highly statistically significant.
Results
During the 4-year study period, a total of 50 episodes of nosocomial candidemia were identified, with an average incidence of 4.23/10,000 discharged (range 1.37-10.5) and an average incidence density of 0.58 episodes/10,000 patient-days/year (range 0.17-1.4) as shown in table 1 . Candidemia episodes were increased from 0.17/10,000 to 1.4/10,000 patient-days/year (p ! 0.0001). Of the 50 episodes, 33 (66%) occurred in males with a median age of 55.8 years (range 17-87). The average length of hospitalization before the onset of candidemia for nosocomal candidemia was 50.1 days (range 11-266). The mean time required for the detection of growth was 3.44 days (range 2-7 days) in the Bactec 9240 system. Thirty-two (64%) patients had stayed in the intensive care unit. All patients had taken antibiotic treatment previously; 36 (72%) used 3 or more antibiotics. Forty-six (92%) patients had central venous catheters, and 41 (82%) had received total parenteral nutrition. The main characteristics of the patients are shown in table 2 .
Candida albicans and non-albicans Candida accounted for 15 (30%) and 35 (70%) episodes, respectively. The species of non-albicans Candida was identified in only 17 (48%) isolates because we began to specify strains after 2006. These included Candida tropicalis (7), Candida parapsilosis (4), Candida glabrata (3) and Candida kefyr (3) . During the 4-year study period, no significant changes were observed in the distribution of Candida species (p = 0.7361).
Twenty-six (52%) patients received antifungal therapy for an average of 18 days (range 12-34). Twenty-four patients were not treated with antifungal drugs because of The presence of a central venous catheter was not significantly associated with mortality because a central venous catheter and a urinary catheter were used in all these patients.
Discussion
The mean incidence density of nosocomial candidemia was 0.58 episodes/10,000 patient-days/year, and this represented a 6-fold increase in the incidence of candidemia in comparison with the period 2004-2007 probably due to excessive use of antibiotics and indwelling devices in our hospital as previously reported [9] .
The epidemiology of candidemia may vary depending on geographic locations, even between units in the same hospital. Although C. albicans has been the predominantly isolated species, there has been a shift in the distribution to the non-albicans Candida species as reported previously [10] [11] [12] and confirmed in our study as the proportion of non-albicans Candida species was 70%. However, this is higher than the previous report of 66% by Bakir et al. [13] . The difference could be due to the frequent use of fluconazole in our hospital.
Generally, candidemia is associated with high morbidity and mortality despite antifungal treatment. Independent risk factors associated with mortality in patients with candidemia have been reported in various studies [14] [15] [16] [17] [18] . Included in the risk factors are advanced age and high scores of the Acute Physiology and Chronic Health Evaluation (APACHE) II [14] , or bacterial sepsis, rapidly fatal illness, chronic obstructive lung disease, presence of a central venous catheter and lack of antifungal therapy [15] ; impaired general condition performance status, low serum albumin, congestive heart failure and shock were independent factors associated with mortality. Inadequate initial therapy and high APACHE III scores [16] were other risk factors, and fungemia itself [17] had a 5-fold higher mortality rate in patients with fungemia in comparison to others. However, Barberino et al. [19] showed that there was no difference in the mortality between cases and controls. They suggested that severity of the underlying disease was a better risk factor of mortality. Gudlaugsson et al. [20] did not report any statistically significant differences in age, sex, underlying disease, surgical procedure or vital signs at admission between cases and controls either. The crude mortality rate among cases did not differ significantly by Candida species either. Some non-albicans Candida species had been associated with a poorer prognosis [21, 22] . Further, Viscoli et al. [22] reported that patients with both candidemia and cancer had a poorer clinical outcome. The high mortality rate of 56% in our study confirmed the previous findings described above. In the univariate analysis, the parameter that was independently associated with mortality was staying in the intensive care unit.
Conclusion
Our study showed that candidemia was associated with a high mortality rate and staying in the intensive care unit was an associated risk factor. There was a significantly increased trend in the incidence of candidemia during the study period most probably due to antibiotic overuse, inadequate infection control and prevention program in our hospital.
